Indivior PLC (LON:INDV - Get Free Report)'s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 803.50 ($10.64) and traded as low as GBX 671 ($8.88). Indivior shares last traded at GBX 687 ($9.09), with a volume of 339,070 shares changing hands.
Indivior Stock Up 0.5 %
The stock has a market cap of £1.07 billion, a PE ratio of -568.38, a P/E/G ratio of -5.57 and a beta of 0.19. The business has a 50 day moving average of GBX 734.84 and a 200-day moving average of GBX 802.78. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
See Also
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
